Feedback / Questions
ASP9801 - Astellas, Tottori University
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT03954067
May 20, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next